Get the Stockscreener App
21.36
0.07%
0.015
Overview
News
Price History
Option Chain
Why BCS Down?
Discussions
Forecast
Stock Split
Dividend History
Barclays Plc Adr stock is traded at $21.36, with a volume of 3.98M.
It is up +0.07% in the last 24 hours and up +3.31% over the past month.
Barclays is a universal bank headquartered in the United Kingdom. It operates via five principal segments; UK (retail), UK corporate bank, private bank and wealth management, investment bank, and US consumer bank. In its UK segment, the bank provides current accounts, mortgages, savings and investment management services, credit cards, and business banking services to retail clients and small and medium-size enterprises. The international segment includes a corporate bank offering banking solutions to large corporates, a bulge-bracket global investment bank, and a credit card business.
See More
Previous Close:
$21.34
Open:
$21.31
24h Volume:
3.98M
Relative Volume:
0.46
Market Cap:
$74.89B
Revenue:
$37.90B
Net Income/Loss:
$7.82B
P/E Ratio:
9.7869
EPS:
2.182
Net Cash Flow:
$182.70B
1W Performance:
+3.26%
1M Performance:
+3.31%
6M Performance:
+32.97%
1Y Performance:
+72.08%
1-Day Range:
$21.27
$21.45
1-Week Range:
$21.07
$21.61
52-Week Range:
$12.14
$21.61
Barclays Plc Adr Stock (BCS) Company Profile
Compare BCS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BCS
Barclays Plc Adr
|
21.36 | 74.21B | 37.90B | 7.82B | 182.70B | 2.182 |
|
JPM
Jpmorgan Chase Co
|
309.36 | 842.36B | 277.90B | 57.74B | 40.06B | 20.19 |
|
BAC
Bank Of America Corp
|
52.95 | 388.68B | 195.02B | 29.65B | 22.38B | 3.6673 |
|
WFC
Wells Fargo Co
|
86.42 | 270.78B | 123.32B | 21.20B | 6.16B | 6.0743 |
|
HSBC
Hsbc Holdings Plc Adr
|
69.81 | 241.97B | 138.28B | 17.44B | 105.99B | 4.7081 |
|
RY
Royal Bank Of Canada
|
146.29 | 205.76B | 96.89B | 13.73B | -34.72B | 9.4824 |
Barclays Plc Adr Stock (BCS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-18-25 | Downgrade | Citigroup | Buy → Neutral |
| Mar-04-25 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Oct-08-24 | Initiated | Goldman | Buy |
| Sep-05-24 | Initiated | Kepler | Buy |
| May-09-24 | Initiated | Deutsche Bank | Buy |
| Oct-26-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-26-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-08-23 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| May-12-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Dec-14-22 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Dec-06-22 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-22-22 | Upgrade | Citigroup | Neutral → Buy |
| Mar-29-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Jan-28-22 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-07-21 | Downgrade | Deutsche Bank | Buy → Hold |
| Sep-30-21 | Upgrade | Redburn | Neutral → Buy |
| Mar-16-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Mar-12-21 | Upgrade | Goldman | Neutral → Buy |
| Nov-10-20 | Downgrade | Investec | Buy → Hold |
| Jul-10-20 | Upgrade | Investec | Hold → Buy |
| Mar-03-20 | Downgrade | Societe Generale | Buy → Hold |
| Feb-11-20 | Resumed | Credit Suisse | Neutral |
| Nov-26-19 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Sep-05-19 | Upgrade | Keefe Bruyette | Underperform → Mkt Perform |
| Aug-21-19 | Upgrade | Exane BNP Paribas | Underperform → Neutral |
| Apr-18-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Oct-01-18 | Upgrade | Berenberg | Hold → Buy |
| Jun-19-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| Apr-16-18 | Upgrade | Jefferies | Hold → Buy |
| Mar-29-18 | Upgrade | Investec | Hold → Buy |
| Mar-20-18 | Downgrade | Investec | Buy → Hold |
| Mar-08-18 | Upgrade | Goldman | Sell → Neutral |
| Jan-11-18 | Downgrade | Keefe Bruyette | Mkt Perform → Underperform |
| Jan-10-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-15-17 | Downgrade | Investec | Buy → Hold |
| Nov-20-17 | Upgrade | BofA/Merrill | Underperform → Buy |
| Oct-31-17 | Upgrade | Keefe Bruyette | Underperform → Mkt Perform |
| Oct-20-17 | Upgrade | Berenberg | Sell → Hold |
View All
Barclays Plc Adr Stock (BCS) Latest News
Barclays Forecasts Strong Price Appreciation for Logitech International (NASDAQ:LOGI) Stock - Defense World
New Aerospike Workshops Deliver Hands-on Build of Real-Time Feature Stores for Predictive, Generative, and Agentic AI Apps - GlobeNewswire Inc.
Barclays PLC Executes Share Transaction within Capital Management Programme - Kalkine Media
Barclays PLC continues disciplined capital actions within the banking sector - Kalkine Media
Barclays PLC (NYSE:BCS) Receives Consensus Rating of “Buy” from Analysts - Defense World
Predictions - sharewise.com
WITTwo Sigma Investments 3Q 13F: Largest Eliminations - ADVFN
Barclays PLC (LSE:BARC) Confirms Completion of Share Transaction - Kalkine Media
RBC Capital Sticks to Its Buy Rating for Barclays (BARC) - The Globe and Mail
Barclays PLC Reports Strong Q3 2025 Earnings - The Globe and Mail
Alibaba Group Holding Ltd ADR diskutieren - sharewise.com
Barclays to cancel shares via £500m buy-back after £1,000m program - Stock Titan
Barclays Q3 Earnings Dip Y/Y as Costs, Credit Impairment Charges Rise - The Globe and Mail
Barclays Up Over 5%, on Pace for Largest Percent Increase Since April -- Data Talk - 富途牛牛
Barclays Financial Update Amid Charges – FTSE 100 Live - Kalkine Media
Barclays ADR earnings missed by $0.46, revenue fell short of estimates - Investing.com
HSBC Holdings (HSBA) Receives a Buy from Barclays - The Globe and Mail
REGBarclays PLC3rd Quarter Results - TradingView
IBN Q2 Earnings Rise Y/Y on Higher NII & Fee Incom, Stock Falls 5.9% - The Globe and Mail
Bank of America Upgraded, Allstate Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
Kepler Capital Remains a Buy on Barclays (BARC) - The Globe and Mail
Morgan Stanley Reaffirms Their Buy Rating on Barclays (BARC) - The Globe and Mail
European, Asian stocks battered by U.S. regional bank worries - MarketWatch
Jefferies Keeps Their Buy Rating on Lloyds Banking (LLOY) - The Globe and Mail
Kepler Capital Sticks to Their Buy Rating for Lloyds Banking (LLOY) - The Globe and Mail
Barclays hits 52-week trading high as the stock continues to rally in 2025 - MSN
Barclays Keeps Their Buy Rating on AstraZeneca (AZN) - The Globe and Mail
Haleon PLC Sponsored ADR (HLN) Gets a Buy from Berenberg Bank - The Globe and Mail
Barclays Reaffirms Their Buy Rating on HSBC Holdings (HSBA) - The Globe and Mail
JEF Stock Slides on Revealing Exposure to Bankrupt First Brands Group - The Globe and Mail
Barclays discloses 3.94% stake in Dalata Hotel Group - Investing.com
Buy the Surge in AMD Stock After Striking Partnership with OpenAI? - The Globe and Mail
Morgan Stanley Remains a Buy on Barclays (BARC) - The Globe and Mail
Trading In London’s Blue Chip Stocks Is Surging — in New York - Bloomberg.com
Barclays files 2024 annual report with SEC - MSN
Case Updater: PCP v Barclays – Waiver of privilege | Latin America | Global law firm - Norton Rose Fulbright
Zacks Investment Ideas feature highlights: General Motors, Tesla, Ford, JPMorgan, Barclays, Citigroup, Goldman Sachs and UBS - The Globe and Mail
SEC Fair Fund Opens $25+ Payment Claims for Barclays Investors During 2019-2022 Trading Period - Stock Titan
GlaxoSmithKline (GSK) Gets a Hold from Barclays - The Globe and Mail
Barclays Sticks to Its Buy Rating for BP p.l.c. (BP) - The Globe and Mail
HSBC Vs. BCS: Which Foreign Bank Deserves A Spot In Your Portfolio? - Barchart.com
HSBC vs. BCS: Which Foreign Bank Deserves a Spot in Your Portfolio? - The Globe and Mail
Barclays discloses 3.87% position in Dalata Hotel Group - Investing.com
3rd UPDATE: Barclays 1st Half Net Profit +10% On Invest Bank; Shares Up - ADVFN
Rhumbline Advisers Reduces Stock Position in Barclays PLC $BCS - Defense World
Elon Musk Just Bought $1 Billion of Tesla Stock, Which Is Up 90% Since Lows Made in April. Is Now the Time for Investors to Go All In? - The Globe and Mail
MacroGenics (NASDAQ:MGNX) Now Covered by Analysts at Barclays - Defense World
Janux Therapeutics (NASDAQ:JANX) Now Covered by Barclays - Defense World
C4 Therapeutics (NASDAQ:CCCC) Now Covered by Barclays - Defense World
Summit Therapeutics (NASDAQ:SMMT) Coverage Initiated by Analysts at Barclays - Defense World
Ralph Lauren (NYSE:RL) Price Target Cut to $353.00 by Analysts at Barclays - Defense World
Barclays Plc Adr Stock (BCS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.46%
0.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):